Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 181,920 | 226,102 | 254,797 | 135,233 | 258,971 |
| Receivables | 48,691 | 44,691 | 50,300 | 45,053 | 38,568 |
| Inventories | 156,432 | 136,643 | 131,529 | 102,931 | 75,329 |
| Other current assets | 12,757 | 3,654 | 12,422 | 10,527 | 8,824 |
| TOTAL | $399,800 | $421,755 | $449,048 | $293,744 | $381,692 |
| Non-Current Assets | |||||
| PPE Net | 394,994 | 369,092 | 344,407 | 298,565 | 250,032 |
| Investments And Advances | 4,288 | 5,912 | 6,438 | 9,378 | 11,137 |
| Intangibles | 884,266 | 884,411 | 665,329 | 899,670 | 674,950 |
| Other Non-Current Assets | 101,589 | 99,293 | 104,716 | 94,054 | 89,321 |
| TOTAL | $1,385,137 | $1,358,708 | $1,120,890 | $1,301,667 | $1,025,440 |
| Total Assets | $1,784,937 | $1,780,463 | $1,569,938 | $1,595,411 | $1,407,132 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 29,202 | 19,928 | 15,445 | 28,056 | 28,014 |
| Accounts payable and accrued liabilities | 33,285 | 32,278 | 25,617 | 21,985 | 36,999 |
| Accrued Expenses | 95,962 | 95,442 | 69,185 | 79,267 | 110,395 |
| Other current liabilities | 809 | 1,172 | 6,180 | N/A | N/A |
| TOTAL | $331,194 | $288,394 | $209,235 | $194,646 | $276,612 |
| Non-Current Liabilities | |||||
| Long Term Debt | 466,076 | 465,079 | 463,864 | 264,270 | 258,370 |
| Deferred Revenues | 86,619 | 71,833 | 41,892 | 28,297 | 30,565 |
| aiOther Non-Current Liabilities | 11,906 | 4,180 | 831 | 16,396 | 28,752 |
| TOTAL | $689,998 | $694,333 | $648,420 | $470,137 | $420,139 |
| Total Liabilities | $1,021,192 | $982,727 | $857,655 | $664,783 | $696,751 |
| Shareholders' Equity | |||||
| Common Shares | 1,607,452 | 1,597,715 | 1,483,065 | 1,363,693 | 1,053,209 |
| Retained earnings | -880,395 | -841,907 | -813,060 | -534,653 | -443,231 |
| Other shareholders' equity | 36,688 | 41,928 | 42,278 | 47,346 | 100,403 |
| TOTAL | $763,745 | $797,736 | $712,283 | $930,628 | $710,381 |
| Total Liabilities And Equity | $1,784,937 | $1,780,463 | $1,569,938 | $1,595,411 | $1,407,132 |